A33 shows similar sensitivity to but is more specific than CDX2 as an immunomarker of colorectal carcinoma

Author:

Wong Newton A C S1ORCID,Adamczyk Lukasz A1,Evans Shanna1,Cullen Jayne1,Oniscu Anca2ORCID,Oien Karin A3

Affiliation:

1. Department of Cellular Pathology; Southmead Hospital; Bristol UK

2. Department of Pathology; Royal Infirmary of Edinburgh; Edinburgh UK

3. Institute of Cancer Sciences; University of Glasgow; Glasgow UK

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Reference24 articles.

1. Metastatic carcinoma of unknown primary: diagnostic approach using immunohistochemistry;Conner;Adv. Anat. Pathol.,2015

2. Cancer of unknown primary site;Pavlidis;Lancet,2012

3. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer;Van Cutsem;N. Engl. J. Med.,2009

4. CDX2 is a useful marker of intestinal-type differentiation: a tissue microarray-based study of 629 tumors from various sites;De Lott;Arch. Pathol. Lab. Med.,2005

5. The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal adenocarcinomas;Kaimaktchiev;Mod. Pathol.,2004

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3